Stem Cell Toxicology and Drug Discovery Applications: iCell Cardiomyocytes plus Molecular Devices Screening Platforms
Tuesday, April 19, 2011 8:00am - 10:00am
The recording from the 2011 CELLULAR IMAGING WEBINAR SERIES: Stem Cell Toxicology and Drug Discovery Applications: iCell Cardiomyocytes plus Molecular Devices Screening Platforms is available now.
Information
Learn how you can automate stem cell assays for drug discovery and toxicology applications.
Induced pluripotent stem (iPS) cells are an ideal source of functional human cells that can be manufactured in large quantities to perform drug screening or test for toxic effects on specific target cell types.
During this webinar, we will demonstrate the utility of using iCell™ Cardiomyocytes in conjunction with ImageXpress® High Content Screening Systems and IonWorks Barracuda™ Automated Patch-Clamp System.
Presenters
- Jayne Hesley, Applications Scientist, Cellular Imaging, Molecular Devices, Inc.
- Blake D. Anson, PhD, Product Manager, iCell Cardiomyocytes, Cellular Dynamics International, Inc.
- Pierre Turpin, PhD, Product Manager, Cellular Imaging, Molecular Devices, Inc.